Predicting disability worsening in relapsing and progressive multiple sclerosis.

Area of Science:

• Neurology
• Immunology
• Clinical Medicine

Background:

• Multiple sclerosis (MS) is a complex neurological disorder with variable clinical progression.
• Predicting disability worsening in MS is challenging due to disease heterogeneity.
• Effective management and treatment decisions require understanding prognostic factors.

Purpose of the Study:

• To review established and emerging predictors of disability worsening in multiple sclerosis.
• To discuss clinical, imaging, and biomarker factors influencing MS progression.
• To explore the impact of early treatment strategies on MS disability accumulation.

Main Methods:

• Literature review of established and emerging predictors of disability worsening in MS.
• Analysis of clinical, imaging, and biomarker data associated with MS progression.
• Evaluation of recent observational studies on early-intensive therapy in MS.

Main Results:

• Clinical factors (age, sex, smoking, obesity, comorbidities) predict MS disability.
• Imaging features (brain/spinal cord atrophy, lesion load, OCT) indicate worsening.
• Neurofilament light chain (NfL) shows promise as a blood biomarker for MS progression.
• Early-intensive therapy may decrease disability accumulation compared to escalated treatment.

Conclusions:

• Identifying predictors of MS disability progression aids patient counseling and treatment.
• A combination of clinical, imaging, and biomarker data offers a comprehensive view of MS prognosis.
• Early intervention with intensive therapies warrants further investigation in randomized controlled trials.